Global Exporter & Bulk Supplier of Hycalieva 2.5 mg Injection

🌍 Strategic Oncology Supply Chain Partner

Are you seeking a reliable international source for Hycalieva 2.5 mg Injection? Ernest Oncology (A specialized division of Ernest Pharmaceutical Pvt. Ltd.) is a premier global exporter of advanced anti-neoplastic medications. We specialize in the high-standard distribution of Topotecan 2.5 mg to specialized clinics, hospitals, and pharmaceutical wholesalers in the USA, UK, Australia, and South Africa.

🔬 1. Product Overview: Hycalieva 2.5 mg Injection

Hycalieva 2.5 mg Injection is a potent chemotherapy agent containing Topotecan Hydrochloride, specifically designed for the management of advanced solid tumors.

• Active Ingredient: Topotecan (2.5 mg per vial).

• Therapeutic Class: Topoisomerase-I Inhibitor (Camptothecin class).

• Formulation: Sterile lyophilized powder for injection (2.5 ml vial).

• Storage: Cold-chain required (Refrigerated).

⚙️ 2. Mechanism of Action

Hycalieva targets cancer cells by interfering with their ability to replicate genetic material:

• DNA Complex Stabilization: It binds to and stabilizes the topoisomerase-I–DNA complex.

• Cell Cycle Arrest: By preventing the re-ligation of DNA strands, it causes double-strand breaks during DNA replication, leading to programmed cell death (apoptosis) in rapidly dividing cancer cells.

🏥 3. Clinical Indications

Hycalieva 2.5 mg is a frontline and second-line treatment option for:

• Ovarian Cancer: Metastatic or recurrent disease following platinum-based therapy.

• Small Cell Lung Cancer (SCLC): Relapsed or refractory cases where initial therapy has faile

• Cervical Cancer: Often used in combination with Cisplatin for advanced stages